Bio-Rad Laboratories BIO
NYSE BIO
$376.96 -3.15 (-0.83%)
As of: Sep 9, 2026 · 12:05 PM EDT

Bio-Rad Laboratories (BIO) Selling, General & Administrative (2009 - 2026)

Analysis

Bio-Rad Laboratories (BIO) Selling, General & Administrative (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Thermo Fisher Scientific 224.92 Bn 220.86 Bn 8.34 Bn 2.33 Bn
2 Danaher 144.28 Bn 139.93 Bn 3.61 Bn 2.07 Bn
3 Agilent Technologies 40.97 Bn 39.21 Bn 1.04 Bn 475.00 Mn
4 Illumina 31.40 Bn 30.23 Bn 770.00 Mn 273.00 Mn
5 Revvity 13.71 Bn 12.68 Bn 416.87 Mn 278.58 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 113.17 Mn
7 Bio-Rad Laboratories 10.08 Bn 8.46 Bn 345.80 Mn 212.00 Mn
8 Repligen 9.47 Bn 8.46 Bn 110.04 Mn 76.62 Mn
9 10x Genomics 8.71 Bn 8.16 Bn 112.50 Mn 78.66 Mn
10 Bruker 8.37 Bn 8.16 Bn 416.00 Mn 238.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 212.00 Mn
Mar 31, 2026 212.40 Mn
Dec 31, 2025 221.00 Mn
Sep 30, 2025 206.80 Mn
Jun 30, 2025 207.70 Mn
Mar 31, 2025 208.80 Mn
Dec 31, 2024 204.00 Mn
Sep 30, 2024 200.40 Mn
Jun 30, 2024 194.70 Mn
Mar 31, 2024 214.90 Mn
Dec 31, 2023 207.12 Mn
Sep 30, 2023 201.20 Mn
Jun 30, 2023 207.82 Mn
Mar 31, 2023 225.55 Mn
Dec 31, 2022 212.20 Mn
Sep 30, 2022 211.11 Mn
Jun 30, 2022 207.79 Mn
Mar 31, 2022 196.69 Mn
Dec 31, 2021 221.69 Mn
Sep 30, 2021 216.15 Mn